In recent years, the GOT1 metabolic pathway has been found to play an important role in many cancers, such as glioblastoma multiforme, small cell lung cancer, pancreatic ductal adenocarcinoma (PDCA), and BC [32–34]. This evidence concerns the gene GOT1 and breast cancer.